Product Code: ETC131329 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The antidiabetic market in the Philippines is expected to show strong growth over the forecast period due to increasing prevalence of diabetes, rising healthcare expenditure, and growing awareness about insulin therapy among people. The demand for antidiabetics is also expected to be driven by the increase in availability of generic drugs and government initiatives such as expanding access to medicines through health insurance
Rapidly developing infrastructure facilities & rising population levels are increasing demand for improved medical treatments including those related to diabetes management thereby leading towards greater need for anti diabetic medication. Additionally, the government regulations encouraging private sector investment into research & development activities along with favorable reimbursement policies have been stimulating diabetic patient`s access & utilization rates thus promoting adoption of anti diabetic drugs. Further, growing focus on personalized medicine has resulted in innovative drug classifications designed specifically according target individuals resulting improved outcomes while reducing cost pressure due high manufacturing efficiency.
High costs associated with certain medications often limit their affordability particularly amongst lower income households or patients without health insurance coverage
Leading players operating within this industry include Novo Nordisk , Sanofi Aventis , Eli Lilly , GlaxoSmithKline etc who specialize in oral formulations such as Metformin or injectables such as Insulin
Philippines Antidiabetics |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Antidiabetics Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Antidiabetics Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Antidiabetics Market - Industry Life Cycle |
3.4 Philippines Antidiabetics Market - Porter's Five Forces |
3.5 Philippines Antidiabetics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Antidiabetics Market Revenues & Volume Share, By Patient Population, 2021 & 2031F |
3.7 Philippines Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Philippines Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Antidiabetics Market Trends |
6 Philippines Antidiabetics Market, By Types |
6.1 Philippines Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Antidiabetics Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Philippines Antidiabetics Market Revenues & Volume, By Insulin , 2021-2031F |
6.1.4 Philippines Antidiabetics Market Revenues & Volume, By Drug Class, 2021-2031F |
6.2 Philippines Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 Philippines Antidiabetics Market Revenues & Volume, By Paediatric, 2021-2031F |
6.2.3 Philippines Antidiabetics Market Revenues & Volume, By Adult, 2021-2031F |
6.2.4 Philippines Antidiabetics Market Revenues & Volume, By Geriatric, 2021-2031F |
6.3 Philippines Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2021-2031F |
6.3.3 Philippines Antidiabetics Market Revenues & Volume, By Insulin pump, 2021-2031F |
6.3.4 Philippines Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2021-2031F |
6.3.5 Philippines Antidiabetics Market Revenues & Volume, By Oral, 2021-2031F |
6.3.6 Philippines Antidiabetics Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Antidiabetics Market Import-Export Trade Statistics |
7.1 Philippines Antidiabetics Market Export to Major Countries |
7.2 Philippines Antidiabetics Market Imports from Major Countries |
8 Philippines Antidiabetics Market Key Performance Indicators |
9 Philippines Antidiabetics Market - Opportunity Assessment |
9.1 Philippines Antidiabetics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Antidiabetics Market Opportunity Assessment, By Patient Population, 2021 & 2031F |
9.3 Philippines Antidiabetics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Philippines Antidiabetics Market - Competitive Landscape |
10.1 Philippines Antidiabetics Market Revenue Share, By Companies, 2024 |
10.2 Philippines Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |